Aptakon Inc is a research-stage antibody production company housed in the Kansas City Biotechnology Development Center. The firm is specializing in protein engineering, process development, and manufacturing. Aptakon hopes to commercialize one or more of several scaffold-protein technologies as diagnostic or research tools that work by detecting very small amounts of proteins in tumor and other tissue samples. The firm is working on development, scale-up and commercial-support activities of unique affinity reagents for biomarkers, critical to commercializing the technologies.
